Paytient Leans Into 2027 Benefits Planning With Cost-Smoothing Push

Paytient is sharpening its focus on employer benefits planning for the 2027 cycle, emphasizing what it calls a point-of-care crisis driven by rising health insurance premiums and high-deductible plan designs. The company cites internal research indicating that about 40% of insured employees are delaying essential medical treatment due to out-of-pocket costs.

Paytient argues that this delayed care not only worsens long-term health outcomes but also erodes workplace productivity, highlighting an estimated 6.3 hours of lost productivity per employee per week. The firm is using these data points to frame the financial and operational risks employers face when workers cannot afford timely care.

To address these challenges, Paytient is promoting a cost-smoothing model that allows employees to spread out-of-pocket medical expenses over time on an interest-free basis. The company positions this approach as a way for CHROs and benefits leaders to mitigate the drawbacks of high-deductible health plans while maintaining cost control.

Recent commentary from Paytient’s Chief People Officer, Iveta Brigis, shared via LinkedIn and a discussion with Employee Benefit News, reinforces the firm’s employer-focused strategy. The messaging centers on closing the healthcare affordability gap for employees and linking financial wellness tools directly to business performance outcomes.

For investors and benefits stakeholders, these developments suggest that Paytient is aiming to expand its role within the employer-sponsored benefits and health-financing market. If employers adopt cost-smoothing solutions at scale during upcoming benefits cycles, the company could see a larger addressable market and more durable, recurring revenue opportunities.

By aligning its product narrative with quantifiable productivity impacts and workforce affordability trends, Paytient is seeking to resonate with large employers and HR decision-makers under pressure to balance costs and competitiveness. Overall, the week’s activity underscores a strategic push to convert thought leadership and research on healthcare affordability into broader commercial adoption.